Cargando…

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis

Non-alcoholic fatty liver disease (NAFLD) is characterized by increased uptake and accumulation of lipids in hepatocytes. Simple steatosis may progress to non-alcoholic steatohepatitis (NASH) with inflammation, hepatocellular injury and fibrosis. CCN1 is an important matrix protein that regulates ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Linling, Sun, Yan, Xue, Hong, Chen, Lin, Gu, Chunyan, Shao, Jianguo, Lu, Rujian, Luo, Xi, Wei, Jue, Ma, Xiong, Bian, Zhaolian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035350/ https://www.ncbi.nlm.nih.gov/pubmed/32081971 http://dx.doi.org/10.1038/s41598-020-60138-8

Ejemplares similares

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression
por: Ju, Linling, et al.
Publicado: (2022)

Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice
por: Wollman, Ayala, et al.
Publicado: (2019)

Steatosis and Steatohepatitis: Complex Disorders
por: Bettermann, Kira, et al.
Publicado: (2014)

Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model
por: Xiao, Jia, et al.
Publicado: (2014)

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
por: Akbari, Rasoul, et al.
Publicado: (2021)

Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy
por: Ji, Guiyuan, et al.
Publicado: (2015)

Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway
por: Lu, Rujian, et al.
Publicado: (2021)

Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model
por: Li, Hua, et al.
Publicado: (2019)

Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
por: Choi, Naeun, et al.
Publicado: (2019)

Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway
por: Xiang, Hongjiao, et al.
Publicado: (2021)

Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
por: Pan, Chelsea S., et al.
Publicado: (2020)

Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis
por: Li, Xiaoya, et al.
Publicado: (2022)

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
por: Cataldi, Mauro, et al.
Publicado: (2021)

Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
por: Starmann, Julia, et al.
Publicado: (2012)

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
por: Yan, Yan, et al.
Publicado: (2020)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease
por: Li, Yaru, et al.
Publicado: (2020)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice
por: Xiong, Xiwen, et al.
Publicado: (2019)

Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
por: Zhang, Zhiguo, et al.
Publicado: (2016)

Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
por: Català-Senent, José F., et al.
Publicado: (2021)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
por: Sánchez-Quevedo, Janet, et al.
Publicado: (2022)

Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice
por: Lowe, Patrick P., et al.
Publicado: (2017)

Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetes
por: Ren, Jing, et al.
Publicado: (2022)

Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice
por: Lowe, Patrick P., et al.
Publicado: (2017)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
por: Vulf, Maria, et al.
Publicado: (2021)

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
por: Saeed, Waqar Khalid, et al.
Publicado: (2018)

Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis
por: Zhou, Peng, et al.
Publicado: (2014)

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
por: Zhang, Yuehui, et al.
Publicado: (2018)

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
por: Hu, Ying-Bin, et al.
Publicado: (2018)

AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line
por: Yehezkel, Adi S., et al.
Publicado: (2023)

Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
por: Yokomori, Hiroaki, et al.
Publicado: (2020)

Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model
por: Hamada, Shintaro, et al.
Publicado: (2022)

Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice
por: Henkel, Anne S., et al.
Publicado: (2018)

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
por: Ferolla, Silvia M., et al.
Publicado: (2016)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ts37vaj8vooqik6shd4n0crtna